{"article_title": "These Are the 20 Drugs Companies Are Paying the Most to Get Doctors to Endorse", "article_keywords": ["paying", "20", "drugs", "endorse", "companies", "disease", "drug", "propublicas", "schizophrenia", "type2", "doctors", "multiple", "abilify", "makers", "diabetes"], "article_url": "http://www.theblaze.com/stories/2015/01/10/these-are-the-20-drugs-companies-are-paying-the-most-to-get-doctors-to-endorse/", "article_text": "Big drug companies spend millions each year trying to get doctors to endorse their products.\n\nBut the big spending isn\u2019t just to get doctors to recommend groundbreaking new drugs \u2014 it\u2019s to get doctors to choose one company\u2019s drug over another, similar drug.\n\nIn an analysis of Affordable Care Act-mandated disclosures, ProPublica\u2019s Charles Ornstein and Ryann Grochowski waded through the massive amounts of cash drug makers shell out trying to get the medical establishment to choose particular versions of one drug of another.\n\nIn the last five months of 2013 alone, drug makers spent some $20 million cozying up to doctors and teaching hospitals.\n\nWhat were they hawking?\n\nAs Business Insider noted, nine of the top 20 drugs that companies are paying the most to promote are competing against another drug in the top 20.\n\nVictoza treats type-2 diabetes, so does Invokana.\n\nLatuda, Abilify Maintena and Abilify all treat schizophrenia.\n\nAccording to ProPublica\u2019s analysis, the real battle drug makers face isn\u2019t to get new pills to consumers \u2014 it\u2019s basic economic competition.\n\nSee the full list below:\n\n1. Victoza, type-2 diabetes 2. Eliquis, anti-clotting drug 3. Brilinta, blood-thinner 4. Invokana, type-2 diabetes 5. Latuda, schizophrenia 6. Xarelto, anti-clotting drug 7. Humira, arthritis, ankylosing spondylitis, Crohn\u2019s disease 8. Tudorza, chronic obstructive pulmonary disease 9. Daliresp,chronic obstructive pulmonary disease 10. Abilify Maintena, schizophrenia 11. Abilify, schizophrenia 12. Linzess, irritable bowel syndrome with constipation, chronic idiopathic constipation 13. Pradaxa, anti-clotting 14. Tradjenta, type-2 diabetes 15. Belviq, weight loss drug 16. Copaxone, multiple sclerosis 17. Samsca, hyponatremia (low sodium levels in the blood) 18. H. P. Acthar, infantile spasms, multiple sclerosis, endocrine disorders, arthritis, lupus 19. Symbicort, asthma 20. Aubagio, multiple sclerosis\n\nRead more about the list at Business Insider, and explore ProPublica\u2019s drug payment information tool here.\n\n\u2014\n\nFollow Zach Noble (@thezachnoble) on Twitter", "article_metadata": {"msapplication-notification": "frequency=30; polling-uri=http://www.theblaze.com/publish/_livetile/notifications/1.xml; polling-uri2=http://www.theblaze.com/publish/_livetile/notifications/2.xml; polling-uri3=http://www.theblaze.com/publish/_livetile/notifications/3.xml; polling-uri4=http://www.theblaze.com/publish/_livetile/notifications/4.xml", "gplus-count": 1, "twitter": {"description": "Big drug companies spend millions each year trying to get doctors to endorse their products.  But the big spending isn't just to get doctors to recommend groundbreaking new drugs \u2014 it's to get doctors to choose one company's drug over another, similar drug.    In an...", "title": "These Are the 20 Drugs Companies Are Paying the Most to Get Doctors to Endorse", "url": "http://www.theblaze.com/stories/2015/01/10/these-are-the-20-drugs-companies-are-paying-the-most-to-get-doctors-to-endorse/", "image": "http://www.theblaze.com/wp-content/uploads/2013/05/Prescription-Drugs-Getty-620x348.jpg", "site": "@theblaze", "card": "summary", "account_id": 1512944287}, "keywords": "these, 20, drugs, companies, paying, most, get, doctors, endorse", "sailthru.tags": "business, drugs, health, author-zach-noble, site-theblazecom", "facebook-count": 144, "application-name": "TheBlaze.com", "msapplication-TileColor": "#282b2d", "msapplication-wide310x150logo": "http://www.theblaze.com/wp-content/plugins/theblaze_livetile/img/wide310x150.png", "categories": "drugs,business,health", "msapplication-square150x150logo": "http://www.theblaze.com/wp-content/plugins/theblaze_livetile/img/medium150x150.png", "comment-count": 61, "description": "Big drug companies spend millions each year trying to get doctors to endorse their products.  But the big spending isn't just to get doctors to recommend groundbreaking new drugs \u2014 it's to get doctors to choose one company's drug over another, similar drug.    In an...", "sailthru.guid": "theblazecom/914741", "linkedin-count": 0, "msapplication-square70x70logo": "http://www.theblaze.com/wp-content/plugins/theblaze_livetile/img/small70x70.png", "msapplication-square310x310logo": "http://www.theblaze.com/wp-content/plugins/theblaze_livetile/img/large310x310.png", "fb": {"admins": 517831498}, "msapplication-starturl": "http://www.theblaze.com/", "viewport": "width=device-width", "og": {"site_name": "The Blaze", "description": "Big drug companies spend millions each year trying to get doctors to endorse their products.  But the big spending isn't just to get doctors to recommend groundbreaking new drugs \u2014 it's to get doctors to choose one company's drug over another, similar drug.    In an...", "title": "These Are the 20 Drugs Companies Are Paying the Most to Get Doctors to Endorse", "url": "http://www.theblaze.com/stories/2015/01/10/these-are-the-20-drugs-companies-are-paying-the-most-to-get-doctors-to-endorse/", "image": {"width": 620, "identifier": "http://www.theblaze.com/wp-content/uploads/2013/05/Prescription-Drugs-Getty-620x348.jpg", "type": "image/jpeg", "height": 348}, "type": "article"}, "dc.date": "2015-01-10T14:15:27+00:00", "twitter-count": 52}, "article_summary": "In the last five months of 2013 alone, drug makers spent some $20 million cozying up to doctors and teaching hospitals.\nAs Business Insider noted, nine of the top 20 drugs that companies are paying the most to promote are competing against another drug in the top 20.\nBut the big spending isn\u2019t just to get doctors to recommend groundbreaking new drugs \u2014 it\u2019s to get doctors to choose one company\u2019s drug over another, similar drug.\nBig drug companies spend millions each year trying to get doctors to endorse their products.\nAccording to ProPublica\u2019s analysis, the real battle drug makers face isn\u2019t to get new pills to consumers \u2014 it\u2019s basic economic competition."}